Why is DRNA Rallying? Top Gainer Approaches All Time High

Written by: Owain Higham


DRNA (Dicerna Pharmacueticals) opened up as the top gainer on the US stock markets today, up +78.57% at the time of writing.


Why is DRNA rallying?

The stock is likely up due to news that Denmark’s Novo Nordisk plans to buy DRNA for $3.3 billion.


In terms of order flow, the stock simply opened up higher, since the news was released pre-market.


What next for DRNA?


There are no certainties in markets, but the 6+ larger layers of bids that have appeared in the order book of DRNA suggest the stock has found support.


There are large bids all the way from 37.85 till 37.5, with the 37.75 level being the largest in terms of liquidity.


Offers are light above, with some levels even showing zero offers.


A swing high price of $40 is only a couple of dollars higher where prices are currently trading, with the all time high at $46.




Disclaimer: This content is for informational purposes only and is not trading advice.


Receive updates about new articles

Follow us on social media

After a relatively volatile week in $ES_F price is now back where we started, hovering around Monday’s open at $3963.75

Could this be our first weekly doji of 2023?

Large buyer on the bid at $3945, sellers on the offer above $3078.

Barboza shares a potential short setup on #TSLA for #bmbluejacket 

"... interesting to see price react off the 5$ increment major liquidity levels like Precision is always talking about🧐"

Join the content competition: https://t.co/OuK8jmIhm1

Don’t sleep on the Stops and Icebergs add-on.

Part of the MBO bundle, it provides real insight into the market - offering something few retail traders have.

More information here: https://t.co/502zztBpER

Learn More About Bookmap